Sourced from:Manufacturer Authorized Distributor
Quick Summary
Verquvo 2.5mg Tablet
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹1518
MRP: ₹1785.9
(You Save ₹267.9)
14 TABLET(s) IN A STRIP
Sourced from:Manufacturer Authorized Distributor
15% OFF
₹1518
MRP: ₹1,785.90
Inclusive of all taxes
15% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Introduction to Verquvo 2.5mg Tablet
Verquvo 2.5mg tablet contains the active substance Vericiguat. It is a cardiovascular agent that belongs to the class of medications called soluble guanylate cyclase stimulator. It is used to reduce the risk of death and the need for hospitalization in certain adults with heart failure. Heart failure occurs when your heart is weak and cannot pump enough blood to your body. Common symptoms of heart failure are shortness of breath, tiredness, or swelling caused by fluid build-up.
Do not take Verquvo 2.5 if you are allergic to Vericiguat or any of the other ingredients of this medicine. Inform your physician if you have low blood pressure with symptoms like dizziness or light-headedness, severe liver or kidney problems, and if you are on dialysis. This medicine is not recommended for children and adolescents under 18. Tell your doctor if you are pregnant or breastfeeding before starting the treatment. Verquvo 2.5 mg substitute options should only be considered under the guidance of a healthcare professional to ensure safe and effective treatment for heart failure.
Do not stop taking this medicine without informing your doctor because it may worsen your condition. The most common side effects of Verquvo 2.5mg are low blood pressure and anemia. Use effective contraception during the treatment and one month after your last dose. If you cannot swallow the tablet whole, it may be crushed and mixed with after immediately before administration.
Uses of Verquvo 2.5mg Tablet
Verquvo 2.5 mg Tablet uses are:
- To reduce the risk of death and hospitalization in adults with heart failure
Therapeutic Effects of Verquvo 2.5mg Tablet
Verquvo 2.5mg tablet is a soluble guanylate cyclase stimulator (an important enzyme in the nitric oxide signaling pathway). Heart failure is associated with impaired synthesis of nitric oxide and decreased activity of this enzyme, which may contribute to myocardial and vascular dysfunction. This medicine works by relaxing the blood vessels in the lungs to allow blood to flow easily.
Interaction of Verquvo 2.5mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, vaccines, nutritional or vitamin supplements, and herbal products. Certain medications interact with tab Verquvo 2.5 and reduce their effectiveness by causing undesirable side effects.
More Information about Verquvo 2.5mg Tablet
- Store verquvo tablet 2.5 mg at 20 to 25°C
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the tablet, take it as soon as you remember. However, skip the missed dose if it is nearly time for the next dose.
How to consume Verquvo 2.5mg Tablet
Always use this medicine as exactly prescribed by your doctor. Depending on the condition being treated, your physician decides the dose, dosage, and duration of the treatment. Take the tablet at the same time every day with food. If you cannot swallow the tablet, you can crush it and mix it with water. Take the mixture immediately.
Safety Advice for Verquvo 2.5mg Tablet
Breast Feeding
Breastfeeding is not recommended in patients taking Verquvo 2.5mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Alcohol
It is not known whether consuming alcohol is safe while taking Verquvo 2.5mg tablet. Consult your physician for more advice.
Liver
Verquvo 2.5mg tablet is safe in patients with mild to moderate liver problems. Dose adjustments are not necessary if you have liver problems. Inform your physician if you have any severe liver disease before initiating the therapy.
Lungs
It is not known whether Verquvo 2.5mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
Verquvo 2.5mg tablet may make you feel drowsy, dizzy, loss of coordination, or can give blurred vision. Do not drive or operate heavy machinery if you experience any of these side effects.
Pregnancy
Do not use Verquvo 2.5mg tablet during pregnancy because it is not known if it harms the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for one month after the last dose.
Side Effects of Verquvo 2.5mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Verquvo 2.5 mg side effects are:
Common
- Low blood pressure (Hypotension)
- Anemia
Word of Advice
Take a dose as soon as you remember. If it is almost time for your next dose, wait until then and take a regular dose. Do not take extra medicine to make up for a missed dose. It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. Inform your doctor if you notice any unusual bleeding or bruising. Your doctor may suggest you to take certain tests to monitor the effectiveness and side effects of the therapy.
FAQs about Verquvo 2.5mg Tablet
Q1.
How long does it take for Verquvo 2.5mg tablet to show its effects?
The effects of Verquvo 2.5mg tablet may vary from person to person. It may take several days to weeks to experience the full benefits of the medication. It is important to continue taking this medicine as prescribed and attend regular follow-up appointments with your healthcare provider.
Q2.
What is the Selected Safety Information for Verquvo 2.5mg tablet?
Females of reproductive potential should not use this medicine. Do not use Verquvo 2.5mg tablet during pregnancy because it is unknown if it harms the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for one month after the last dose.
Q3.
What are the most common adverse reactions for Verquvo 2.5mg tablet?
The most common side effects of this medicine are hypotension and anemia. Inform your physician if you face any of these side effects.
Q4.
What drug-drug interacts with Verquvo 2.5mg tablet?
Drugs belonging to the same class and drugs used to treat erectile dysfunction interact with Verquvo 2.5mg tablet. Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, vaccines, nutritional or vitamin supplements, and herbal products.
Q5.
Can patients with kidney problems take Verquvo 2.5mg tablet?
Patients with mild to moderate kidney diseases can take Verquvo 2.5mg tablet. Dose adjustments are necessary only for patients with severe kidney failure and those undergoing dialysis. Inform your physician if you have kidney problems before initiating the treatment.
Fact Box of Verquvo 2.5mg Tablet
Molecule Name: Vericiguat
| Therapeutic Class: Cardiovascular agents |
| Pharmacological Class: Soluble guanylate cyclase stimulator | Indications: To reduce the risk of death and hospitalization in adults with heart failure |
References
- Verquvo 10 mg film-coated tablets - Patient Information Leaflet (PIL) - (emc). www.medicines.org.uk. [revised 2021] [cited 2023 Jun 3]. Available from: https://www.medicines.org.uk/emc/product/12775/pil
- Merk&Co., Vericiguat film-coated tablets. Access.fda.gov. [revised 2021 Jan] [cited 2023 Jun 3]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214377s000lbl.pdf
- Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine. [Published 2020 May 14] [cited 2023 Jun 3];382(20):1883–93. Available from: https://pubmed.ncbi.nlm.nih.gov/32222134/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Karpagam A.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
